DOCSLIB.ORG

Analysis of the Expression and Single-Nucleotide Variant Frequencies of the Buyrophilin-Like 2 Gene in Patients with Uveal Melanoma

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Analysis of the Expression and Single-Nucleotide Variant Frequencies of the Buyrophilin-Like 2 Gene in Patients with Uveal Melanoma Supplementary Online Content Amaro A, Parodi F, Diedrich K, et al. Analysis of the expression and single-nucleotide variant frequencies of the buyrophilin-like 2 gene in patients with uveal melanoma. JAMA Ophthalmol. Published online August 11, 2016. doi: 10.1001/jamaophthalmol.2016.2691. eTable 1. M1- and M2-poloarization genes eTable 2. M1- and M2-polarization genes that are associated with disease-free survival of patients with uveal melanoma This supplementary material has been provided by the authors to give readers additional information about their work. © 2016 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 09/30/2021 eTable 1. M1- and M2-poloarization genes 203308_x NM_000195 | HPS1 3257 Hs.40456 203308_x 10 GO:00070 - AI185798 Hermansky-Pudlak syndrome 1 chr10:100 1E+08 1E+08 -1.13131 6.095084 0.859709 0.14105 1.819564 205022_s NM_001085471 FOXN3 1112 Hs.43428 205022_s 14 GO:00000 - NM_0051 forkhead box N3 chr14:896 89622516 90085494 -0.83339 6.106332 1.983495 0.324826 3.850649 204226_a NM_001164380 STAU2 27067 Hs.56181 204226_a 8 GO:00068 - NM_0143 staufen, RNA binding protein, chr8:7446 74461843 74659943 -0.95841 6.106973 0.850648 0.139291 1.804766 208639_x NM_005742 | PDIA6 10130 Hs.21210 208639_x 2 GO:00064 - BC001312 protein disulfide isomerase chr2:1092 10923518 10952960 -0.37258 6.110976 1.043652 0.170783 2.061971 204295_a NA NA NA NA 204295_a NA NA NA NM_0031 NA chrNA:-1-- -1 -1 -0.94773 6.113623 0.686679 0.112319 1.613194 202609_a NM_004447 | EPS8 2059 Hs.59116 202609_a 12 GO:00071 - NM_0044 epidermal growth factor chr12:157 15773075 15942510 -1.30353 6.122138 3.44239 0.562286 10.58922 204290_s NM_005589 | ALDH6A1 4329 Hs.29397 204290_s 14 GO:00551 - NM_0055 aldehyde dehydrogenase 6 chr14:745 74526873 74551196 -0.94848 6.123863 1.719006 0.280706 3.370511 212804_s NM_015635 | GAPVD1 26130 Hs.49513 212804_s 9 GO:00071 + AI797397 GTPase activating protein and chr9:1280 1.28E+08 1.28E+08 0.130083 6.123958 0.852913 0.139275 1.799541 52940_at NA NA NA NA 52940_at NA NA NA AA08576 NA chrNA:-1-- -1 -1 2.969083 6.124078 1.110866 0.181393 2.155788 41047_at NM_024112 | C9orf16 79095 Hs.52241 41047_at 9 GO:00081 + AI885170 chromosome 9 open reading chr9:1309 1.31E+08 1.31E+08 2.627325 6.128819 1.1017 0.179757 2.141424 217886_a NM_001159969 EPS15 2060 Hs.83722 217886_a 1 GO:00071 - BF213575 epidermal growth factor chr1:5181 51819934 51984995 0.766401 6.129662 0.871296 0.142144 1.838149 209083_a NM_007074 | CORO1A 11151 Hs.41506 209083_a 16 GO:00018 + U34690 coronin, actin binding protein, chr16:301 30194925 30200396 -0.31881 6.130288 1.479329 0.241315 2.808291 204487_s NM_000218 | KCNQ1 3784 Hs.95162 204487_s 11 GO:00069 + NM_0002 potassium voltage-gated chr11:246 2466220 2870339 -0.91602 6.135376 1.733615 0.282561 3.243998 218124_a NM_017750 | RETSAT 54884 Hs.44040 218124_a 2 GO:00551 - NM_0177 retinol saturase (all-trans- chr2:8556 85569078 85581821 0.798797 6.136715 1.058639 0.172509 2.091179 200652_a NM_003145 | SSR2 6746 Hs.74564 200652_a 1 GO:00066 - NM_0031 signal sequence receptor, beta chr1:1559 1.56E+08 1.56E+08 -3.04633 6.142696 0.660982 0.107605 1.58265 212640_a NM_198402 | PTPLB 201562 Hs.70548 212640_a 3 GO:00160 - AV71260 protein tyrosine phosphatase- chr3:1232 1.23E+08 1.23E+08 0.109175 6.146216 2.715988 0.441896 6.180602 200926_a NM_001025 | RPS23 6228 Hs.52719 200926_a 5 GO:00064 - NM_0010 ribosomal protein S23 chr5:8156 81569140 81574235 -2.33082 6.147136 0.584687 0.095115 1.498846 211329_x NM_000410 | HFE 3077 Hs.23332 211329_x 6 GO:00024 + AF115264 hemochromatosis chr6:2608 26087508 26095469 -0.04912 6.147206 1.059956 0.172429 2.084085 204950_a NM_014959 | CARD8 22900 Hs.44614 204950_a 19 GO:00429 - NM_0149 caspase recruitment domain chr19:487 48711343 48752925 -0.84366 6.152741 1.905161 0.309644 3.846062 202185_a NM_001084 | PLOD3 8985 Hs.15335 202185_a 7 GO:00551 - NM_0010 procollagen-lysine, 2- chr7:1008 1.01E+08 1.01E+08 -1.43903 6.156429 1.023681 0.166278 2.024901 221879_a NM_001031733 CALML4 91860 Hs.70955 221879_a 15 GO:00055 - AA88633 calmodulin-like 4 chr15:684 68483043 68498448 1.751208 6.157943 1.824663 0.29631 3.481771 214221_a NM_015120 | ALMS1 7840 Hs.18472 214221_a 2 GO:00069 + AI825212 Alstrom syndrome 1 chr2:7361 73612885 73837046 0.306488 6.158164 0.682931 0.110899 1.603871 213103_a NM_052851 | STARD13 90627 Hs.50770 213103_a 13 GO:00071 - AA12802 StAR-related lipid transfer chr13:336 33677272 33859901 0.1677 6.164741 1.521691 0.246838 2.881072 209240_a NM_181672 | OGT 8473 Hs.40541 209240_a X GO:00071 + AF070560 O-linked N-acetylglucosamine chrX:7075 70752911 70795747 -0.29981 6.169447 1.209091 0.19598 2.323459 65630_at NM_001042463 TMEM80 283232 Hs.44866 65630_at 11 GO:00160 + AI742455 transmembrane protein 80 chr11:695 695615 704127 3.554588 6.169681 1.490491 0.241583 2.859872 202316_x NM_001105562 UBE4B 10277 Hs.59397 202316_x 1 GO:00002 + AW24171 ubiquitination factor E4B (UFD2 chr1:1009 10093015 10241294 -1.3948 6.170145 1.253303 0.203124 2.369068 206492_a NM_001166243 FHIT 2272 Hs.65599 206492_a 3 GO:00062 - NM_0020 fragile histidine triad gene chr3:5973 59735037 61237133 -0.63671 6.171241 0.715333 0.115914 1.63816 201347_x NM_012203 | GRHPR 9380 Hs.15574 201347_x 9 GO:00551 + NM_0122 glyoxylate chr9:3742 37422706 37436986 -1.87051 6.174938 0.841456 0.13627 1.788451 211668_s NM_001145031 PLAU 5328 Hs.77274 211668_s 10 GO:00015 + K03226 plasminogen activator, chr10:756 75670861 75677256 -0.00818 6.187258 2.016798 0.32596 4.101064 200598_s NM_003299 | HSP90B1 7184 Hs.19237 200598_s 12 GO:00016 + AI582238 heat shock protein 90kDa beta chr12:104 1.04E+08 1.04E+08 -3.37115 6.194171 1.660065 0.268004 3.093477 202605_a NM_000181 | GUSB 2990 Hs.25523 202605_a 7 GO:00081 - NM_0001 glucuronidase, beta chr7:6542 65425674 65447301 -1.30482 6.19799 1.50091 0.242161 2.826573 202665_s NM_001077269 WIPF1 7456 Hs.12806 202665_s 2 GO:00300 - NM_0033 WAS/WASL interacting protein chr2:1754 1.75E+08 1.76E+08 -1.28676 6.206483 0.796574 0.128345 1.743269 221194_s NM_016125 | RNFT1 51136 Hs.53170 221194_s 17 GO:00160 - NM_0161 ring finger protein, chr17:580 58029723 58042117 1.434372 6.207411 1.056306 0.170169 2.067375 203332_s NM_001017915 INPP5D 3635 Hs.26288 203332_s 2 GO:00067 + NM_0055 inositol polyphosphate-5- chr2:2339 2.34E+08 2.34E+08 -1.12618 6.211592 1.264531 0.203576 2.383988 203959_s NM_001083621 ZBTB40 9923 Hs.41896 203959_s 1 GO:00454 + NM_0148 zinc finger and BTB domain chr1:2277 22778343 22857650 -1.00454 6.21406 0.940932 0.15142 1.92485 222200_s NM_001143888 BSDC1 55108 Hs.35345 222200_s 1 NA - AK021440 BSD domain containing 1 chr1:3283 32830706 32860062 1.997938 6.214454 0.715455 0.115128 1.641197 214264_s NM_145231 | C14orf14 90141 Hs.12323 214264_s 14 GO:00055 - AI656610 chromosome 14 open reading chr14:902 90263470 90421089 0.311507 6.221441 0.894347 0.143752 1.855304 208033_s NM_001164766 ZFHX3 463 Hs.59829 208033_s 16 GO:00001 - NM_0068 zinc finger homeobox 3 chr16:728 72816787 73092534 -0.44621 6.222348 1.580732 0.254041 3.044483 215440_s NM_001080425 BEX4 56271 Hs.18473 215440_s X GO:00056 + AL523320 brain expressed, X-linked 4 chrX:1024 1.02E+08 1.02E+08 0.454995 6.225579 1.103029 0.177177 2.160216 210872_x NM_001130831 GAS7 8522 Hs.46221 210872_x 17 GO:00510 - BC001152 growth arrest-specific 7 chr17:981 9813925 10101868 -0.10121 6.228061 2.069179 0.332235 4.327868 214873_a NM_001135772 LRP5L 91355 Hs.63405 214873_a 22 GO:00160 - AL137651 low density lipoprotein chr22:257 25747385 25777544 0.384872 6.228202 0.687182 0.110334 1.606742 202164_s NM_004779 | CNOT8 9337 Hs.26703 202164_s 5 GO:00063 + AF180476 CCR4-NOT transcription chr5:1542 1.54E+08 1.54E+08 -1.44737 6.228693 1.453202 0.233308 2.695546 203357_s NM_014296 | CAPN7 23473 Hs.59523 203357_s 3 GO:00065 + NM_0142 calpain 7 chr3:1524 15247732 15294422 -1.12137 6.239099 1.577948 0.252913 2.987047 221036_s NM_001145646 APH1B 83464 Hs.51170 221036_s 15 GO:00069 + NM_0313 anterior pharynx defective 1 chr15:635 63569748 63601324 1.381998 6.240169 0.727292 0.11655 1.658962 201365_a NM_002537 | OAZ2 4947 Hs.74563 201365_a 15 GO:00065 - NM_0025 ornithine decarboxylase chr15:649 64979772 64995462 -1.85679 6.24722 0.844551 0.135188 1.791604 212248_a NM_178812 | MTDH 92140 Hs.37715 212248_a 8 GO:00001 + AI886796 metadherin chr8:9865 98656406 98742487 0.06131 6.250295 1.72747 0.276382 3.253897 © 2016 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 09/30/2021 203613_s NM_002493 | NDUFB6 4712 Hs.49366 203613_s 9 GO:00061 - NM_0024 NADH dehydrogenase chr9:3255 32553522 32573182 -1.0699 6.252187 0.771374 0.123377 1.703633 202455_a NM_001015053 HDAC5 10014 Hs.43878 202455_a 17 GO:00063 - NM_0054 histone deacetylase 5 chr17:421 42154120 42201014 -1.35005 6.257979 1.852768 0.296065 3.608243 204392_a NM_003656 | CAMK1 8536 Hs.43487 204392_a 3 GO:00071 - NM_0036 calcium/calmodulin-dependent chr3:9799 9799032 9811661 -0.93179 6.258085 2.536383 0.405297 5.586291 202386_s NM_014647 | KIAA0430 9665 Hs.17352 202386_s 16 GO:00057 - NM_0190 KIAA0430 chr16:156 15688244 15737009 -1.37221 6.260295 1.422592 0.22724 2.698285 55616_at NM_033419 | PGAP3 93210 Hs.46297 55616_at 17 GO:00065 - AI703342 post-GPI attachment to proteins chr17:378 37827375 37844310 3.046334 6.261788 0.64587 0.103145 1.564355 211105_s NM_006162 | NFATC1 4772 Hs.53407 211105_s 18 GO:00063 + U80918 nuclear factor of activated T- chr18:771 77155771 77228177 -0.07372 6.265355 1.238266 0.197637 2.369657 218041_x NM_018976 | SLC38A2 54407 Hs.22184 218041_x 12 GO:00068 - NM_0185
Load more

Recommended publications
  • Myotubular Myopathy Caused by Multiple Abnormal Splicing Variants in the MTM1 RNA in a Patient with a Mild Phenotype
    European Journal of Human Genetics (2012) 20, 701–704 & 2012 Macmillan Publishers Limited All rights reserved 1018-4813/12 www.nature.com/ejhg SHORT REPORT Myotubular myopathy caused by multiple abnormal splicing variants in the MTM1 RNA in a patient with a mild phenotype Nasim Vasli1,2,3,4, Vincent Laugel5, Johann Bo¨hm1,2,3,4,Be´atrice Lannes6, Vale´rie Biancalana1,2,3,4,7and Jocelyn Laporte*,1,2,3,4 Mutations impacting on the splicing of pre-mRNA are one important cause of genetically inherited diseases. However, detection of splice mutations, that are mainly due to intronic variations, and characterization of their effects are usually not performed as a first approach during genetic diagnosis. X-linked recessive myotubular myopathy is a severe congenital myopathy due to mutations in the MTM1 gene encoding myotubularin. Here, we screened a male patient showing an unusually mild phenotype without respiratory distress by western blot with specific myotubularin antibodies and detected a strong reduction of the protein level.The disease was subsequently linked to a hemizygous point mutation affecting the acceptor splice site of exon 8 of MTM1, proven by protein, transcript and genomic DNA analysis. Detailed analysis of the MTM1 mRNA by RT-PCR, sequencing and quantitative PCR revealed multiple abnormal transcripts with retention of a truncated exon 8, and neighboring exons 7 and 9 but exclusion of several other exons, suggesting a complex effect of this mutation on the splicing of non-adjacent exons. We conclude that the analysis of RNA by RT-PCR and sequencing is an important step to characterize the precise impact of detected splice variants.
    [Show full text]
  • Supplementary Materials: Evaluation of Cytotoxicity and Α-Glucosidase Inhibitory Activity of Amide and Polyamino-Derivatives of Lupane Triterpenoids
    Supplementary Materials: Evaluation of cytotoxicity and α-glucosidase inhibitory activity of amide and polyamino-derivatives of lupane triterpenoids Oxana B. Kazakova1*, Gul'nara V. Giniyatullina1, Akhat G. Mustafin1, Denis A. Babkov2, Elena V. Sokolova2, Alexander A. Spasov2* 1Ufa Institute of Chemistry of the Ufa Federal Research Centre of the Russian Academy of Sciences, 71, pr. Oktyabrya, 450054 Ufa, Russian Federation 2Scientific Center for Innovative Drugs, Volgograd State Medical University, Novorossiyskaya st. 39, Volgograd 400087, Russian Federation Correspondence Prof. Dr. Oxana B. Kazakova Ufa Institute of Chemistry of the Ufa Federal Research Centre of the Russian Academy of Sciences 71 Prospeсt Oktyabrya Ufa, 450054 Russian Federation E-mail: [email protected] Prof. Dr. Alexander A. Spasov Scientific Center for Innovative Drugs of the Volgograd State Medical University 39 Novorossiyskaya st. Volgograd, 400087 Russian Federation E-mail: [email protected] Figure S1. 1H and 13C of compound 2. H NH N H O H O H 2 2 Figure S2. 1H and 13C of compound 4. NH2 O H O H CH3 O O H H3C O H 4 3 Figure S3. Anticancer screening data of compound 2 at single dose assay 4 Figure S4. Anticancer screening data of compound 7 at single dose assay 5 Figure S5. Anticancer screening data of compound 8 at single dose assay 6 Figure S6. Anticancer screening data of compound 9 at single dose assay 7 Figure S7. Anticancer screening data of compound 12 at single dose assay 8 Figure S8. Anticancer screening data of compound 13 at single dose assay 9 Figure S9. Anticancer screening data of compound 14 at single dose assay 10 Figure S10.
    [Show full text]
  • Supplement 1 Overview of Dystonia Genes
    Supplement 1 Overview of genes that may cause dystonia in children and adolescents Gene (OMIM) Disease name/phenotype Mode of inheritance 1: (Formerly called) Primary dystonias (DYTs): TOR1A (605204) DYT1: Early-onset generalized AD primary torsion dystonia (PTD) TUBB4A (602662) DYT4: Whispering dystonia AD GCH1 (600225) DYT5: GTP-cyclohydrolase 1 AD deficiency THAP1 (609520) DYT6: Adolescent onset torsion AD dystonia, mixed type PNKD/MR1 (609023) DYT8: Paroxysmal non- AD kinesigenic dyskinesia SLC2A1 (138140) DYT9/18: Paroxysmal choreoathetosis with episodic AD ataxia and spasticity/GLUT1 deficiency syndrome-1 PRRT2 (614386) DYT10: Paroxysmal kinesigenic AD dyskinesia SGCE (604149) DYT11: Myoclonus-dystonia AD ATP1A3 (182350) DYT12: Rapid-onset dystonia AD parkinsonism PRKRA (603424) DYT16: Young-onset dystonia AR parkinsonism ANO3 (610110) DYT24: Primary focal dystonia AD GNAL (139312) DYT25: Primary torsion dystonia AD 2: Inborn errors of metabolism: GCDH (608801) Glutaric aciduria type 1 AR PCCA (232000) Propionic aciduria AR PCCB (232050) Propionic aciduria AR MUT (609058) Methylmalonic aciduria AR MMAA (607481) Cobalamin A deficiency AR MMAB (607568) Cobalamin B deficiency AR MMACHC (609831) Cobalamin C deficiency AR C2orf25 (611935) Cobalamin D deficiency AR MTRR (602568) Cobalamin E deficiency AR LMBRD1 (612625) Cobalamin F deficiency AR MTR (156570) Cobalamin G deficiency AR CBS (613381) Homocysteinuria AR PCBD (126090) Hyperphelaninemia variant D AR TH (191290) Tyrosine hydroxylase deficiency AR SPR (182125) Sepiaterine reductase
    [Show full text]
  • Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model
    Downloaded from http://www.jimmunol.org/ by guest on September 25, 2021 T + is online at: average * The Journal of Immunology , 34 of which you can access for free at: 2016; 197:1477-1488; Prepublished online 1 July from submission to initial decision 4 weeks from acceptance to publication 2016; doi: 10.4049/jimmunol.1600589 http://www.jimmunol.org/content/197/4/1477 Molecular Profile of Tumor-Specific CD8 Cell Hypofunction in a Transplantable Murine Cancer Model Katherine A. Waugh, Sonia M. Leach, Brandon L. Moore, Tullia C. Bruno, Jonathan D. Buhrman and Jill E. Slansky J Immunol cites 95 articles Submit online. Every submission reviewed by practicing scientists ? is published twice each month by Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts http://jimmunol.org/subscription Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html http://www.jimmunol.org/content/suppl/2016/07/01/jimmunol.160058 9.DCSupplemental This article http://www.jimmunol.org/content/197/4/1477.full#ref-list-1 Information about subscribing to The JI No Triage! Fast Publication! Rapid Reviews! 30 days* Why • • • Material References Permissions Email Alerts Subscription Supplementary The Journal of Immunology The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2016 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. This information is current as of September 25, 2021. The Journal of Immunology Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model Katherine A.
    [Show full text]
  • Examination of the Transcription Factors Acting in Bone Marrow
    THESIS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY (PHD) Examination of the transcription factors acting in bone marrow derived macrophages by Gergely Nagy Supervisor: Dr. Endre Barta UNIVERSITY OF DEBRECEN DOCTORAL SCHOOL OF MOLECULAR CELL AND IMMUNE BIOLOGY DEBRECEN, 2016 Table of contents Table of contents ........................................................................................................................ 2 1. Introduction ............................................................................................................................ 5 1.1. Transcriptional regulation ................................................................................................... 5 1.1.1. Transcriptional initiation .................................................................................................. 5 1.1.2. Co-regulators and histone modifications .......................................................................... 8 1.2. Promoter and enhancer sequences guiding transcription factors ...................................... 11 1.2.1. General transcription factors .......................................................................................... 11 1.2.2. The ETS superfamily ..................................................................................................... 17 1.2.3. The AP-1 and CREB proteins ........................................................................................ 20 1.2.4. Other promoter specific transcription factor families ...................................................
    [Show full text]
  • Assessment of a Targeted Gene Panel for Identification of Genes Associated with Movement Disorders
    Supplementary Online Content Montaut S, Tranchant C, Drouot N, et al; French Parkinson’s and Movement Disorders Consortium. Assessment of a targeted gene panel for identification of genes associated with movement disorders. JAMA Neurol. Published online June 18, 2018. doi:10.1001/jamaneurol.2018.1478 eMethods. Supplemental methods. eTable 1. Name, phenotype and inheritance of the genes included in the panel. eTable 2. Probable pathogenic variants identified in a cohort of 23 patients with cerebellar ataxia using WES analysis. eTable 3. Negative cases in a cohort of 23 patients with cerebellar ataxia studied using WES analysis. eTable 4. Variants of unknown significance (VUSs) identified in the cohort. eFigure 1. Examples of pedigrees of cases with identified causative variants. eFigure 2. Pedigrees suggesting mendelian inheritance in negative cases. eFigure 3. Examples of pedigrees of cases with identified VUSs. eResults. Supplemental results. This supplementary material has been provided by the authors to give readers additional information about their work. © 2018 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 09/26/2021 eMethods. Supplemental methods Patients selection In the multicentric, prospective study, patients were selected from 25 French, 1 Luxembourg and 1 Algerian tertiary MDs centers between September 2014 and July 2016. Inclusion criteria were patients (1) who had developed one or several chronic MDs (2) with an age of onset below 40 years and/or presence of a family history of MDs. Patients suffering from essential tremor, tic or Gilles de la Tourette syndrome, pure cerebellar ataxia or with clinical/paraclinical findings suggestive of an acquired cause were excluded.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Identification and Characterization of RHOA-Interacting Proteins in Bovine Spermatozoa1
    BIOLOGY OF REPRODUCTION 78, 184–192 (2008) Published online before print 10 October 2007. DOI 10.1095/biolreprod.107.062943 Identification and Characterization of RHOA-Interacting Proteins in Bovine Spermatozoa1 Sarah E. Fiedler, Malini Bajpai, and Daniel W. Carr2 Department of Medicine, Oregon Health & Sciences University and Veterans Affairs Medical Center, Portland, Oregon 97239 ABSTRACT Guanine nucleotide exchange factors (GEFs) catalyze the GDP for GTP exchange [2]. Activation is negatively regulated by In somatic cells, RHOA mediates actin dynamics through a both guanine nucleotide dissociation inhibitors (RHO GDIs) GNA13-mediated signaling cascade involving RHO kinase and GTPase-activating proteins (GAPs) [1, 2]. Endogenous (ROCK), LIM kinase (LIMK), and cofilin. RHOA can be RHO can be inactivated via C3 exoenzyme ADP-ribosylation, negatively regulated by protein kinase A (PRKA), and it and studies have demonstrated RHO involvement in actin-based interacts with members of the A-kinase anchoring (AKAP) cytoskeletal response to extracellular signals, including lyso- family via intermediary proteins. In spermatozoa, actin poly- merization precedes the acrosome reaction, which is necessary phosphatidic acid (LPA) [2–4]. LPA is known to signal through for normal fertility. The present study was undertaken to G-protein-coupled receptors (GPCRs) [4, 5]; specifically, LPA- determine whether the GNA13-mediated RHOA signaling activated GNA13 (formerly Ga13) promotes RHO activation pathway may be involved in acrosome reaction in bovine through GEFs [4, 6]. Activated RHO-GTP then signals RHO caudal sperm, and whether AKAPs may be involved in its kinase (ROCK), resulting in the phosphorylation and activation targeting and regulation. GNA13, RHOA, ROCK2, LIMK2, and of LIM-kinase (LIMK), which in turn phosphorylates and cofilin were all detected by Western blot in bovine caudal inactivates cofilin, an actin depolymerizer, the end result being sperm.
    [Show full text]
  • Integrating Single-Step GWAS and Bipartite Networks Reconstruction Provides Novel Insights Into Yearling Weight and Carcass Traits in Hanwoo Beef Cattle
    animals Article Integrating Single-Step GWAS and Bipartite Networks Reconstruction Provides Novel Insights into Yearling Weight and Carcass Traits in Hanwoo Beef Cattle Masoumeh Naserkheil 1 , Abolfazl Bahrami 1 , Deukhwan Lee 2,* and Hossein Mehrban 3 1 Department of Animal Science, University College of Agriculture and Natural Resources, University of Tehran, Karaj 77871-31587, Iran; [email protected] (M.N.); [email protected] (A.B.) 2 Department of Animal Life and Environment Sciences, Hankyong National University, Jungang-ro 327, Anseong-si, Gyeonggi-do 17579, Korea 3 Department of Animal Science, Shahrekord University, Shahrekord 88186-34141, Iran; [email protected] * Correspondence: [email protected]; Tel.: +82-31-670-5091 Received: 25 August 2020; Accepted: 6 October 2020; Published: 9 October 2020 Simple Summary: Hanwoo is an indigenous cattle breed in Korea and popular for meat production owing to its rapid growth and high-quality meat. Its yearling weight and carcass traits (backfat thickness, carcass weight, eye muscle area, and marbling score) are economically important for the selection of young and proven bulls. In recent decades, the advent of high throughput genotyping technologies has made it possible to perform genome-wide association studies (GWAS) for the detection of genomic regions associated with traits of economic interest in different species. In this study, we conducted a weighted single-step genome-wide association study which combines all genotypes, phenotypes and pedigree data in one step (ssGBLUP). It allows for the use of all SNPs simultaneously along with all phenotypes from genotyped and ungenotyped animals. Our results revealed 33 relevant genomic regions related to the traits of interest.
    [Show full text]
  • Transcriptome Sequencing and Genome-Wide Association Analyses Reveal Lysosomal Function and Actin Cytoskeleton Remodeling in Schizophrenia and Bipolar Disorder
    Molecular Psychiatry (2015) 20, 563–572 © 2015 Macmillan Publishers Limited All rights reserved 1359-4184/15 www.nature.com/mp ORIGINAL ARTICLE Transcriptome sequencing and genome-wide association analyses reveal lysosomal function and actin cytoskeleton remodeling in schizophrenia and bipolar disorder Z Zhao1,6,JXu2,6, J Chen3,6, S Kim4, M Reimers3, S-A Bacanu3,HYu1, C Liu5, J Sun1, Q Wang1, P Jia1,FXu2, Y Zhang2, KS Kendler3, Z Peng2 and X Chen3 Schizophrenia (SCZ) and bipolar disorder (BPD) are severe mental disorders with high heritability. Clinicians have long noticed the similarities of clinic symptoms between these disorders. In recent years, accumulating evidence indicates some shared genetic liabilities. However, what is shared remains elusive. In this study, we conducted whole transcriptome analysis of post-mortem brain tissues (cingulate cortex) from SCZ, BPD and control subjects, and identified differentially expressed genes in these disorders. We found 105 and 153 genes differentially expressed in SCZ and BPD, respectively. By comparing the t-test scores, we found that many of the genes differentially expressed in SCZ and BPD are concordant in their expression level (q ⩽ 0.01, 53 genes; q ⩽ 0.05, 213 genes; q ⩽ 0.1, 885 genes). Using genome-wide association data from the Psychiatric Genomics Consortium, we found that these differentially and concordantly expressed genes were enriched in association signals for both SCZ (Po10 − 7) and BPD (P = 0.029). To our knowledge, this is the first time that a substantially large number of genes show concordant expression and association for both SCZ and BPD. Pathway analyses of these genes indicated that they are involved in the lysosome, Fc gamma receptor-mediated phagocytosis, regulation of actin cytoskeleton pathways, along with several cancer pathways.
    [Show full text]
  • Mechanisms of Synaptic Plasticity Mediated by Clathrin Adaptor-Protein Complexes 1 and 2 in Mice
    Mechanisms of synaptic plasticity mediated by Clathrin Adaptor-protein complexes 1 and 2 in mice Dissertation for the award of the degree “Doctor rerum naturalium” at the Georg-August-University Göttingen within the doctoral program “Molecular Biology of Cells” of the Georg-August University School of Science (GAUSS) Submitted by Ratnakar Mishra Born in Birpur, Bihar, India Göttingen, Germany 2019 1 Members of the Thesis Committee Prof. Dr. Peter Schu Institute for Cellular Biochemistry, (Supervisor and first referee) University Medical Center Göttingen, Germany Dr. Hans Dieter Schmitt Neurobiology, Max Planck Institute (Second referee) for Biophysical Chemistry, Göttingen, Germany Prof. Dr. med. Thomas A. Bayer Division of Molecular Psychiatry, University Medical Center, Göttingen, Germany Additional Members of the Examination Board Prof. Dr. Silvio O. Rizzoli Department of Neuro-and Sensory Physiology, University Medical Center Göttingen, Germany Dr. Roland Dosch Institute of Developmental Biochemistry, University Medical Center Göttingen, Germany Prof. Dr. med. Martin Oppermann Institute of Cellular and Molecular Immunology, University Medical Center, Göttingen, Germany Date of oral examination: 14th may 2019 2 Table of Contents List of abbreviations ................................................................................. 5 Abstract ................................................................................................... 7 Chapter 1: Introduction ............................................................................
    [Show full text]
  • Chemical Genetic Screen Identifies Gapex-5/GAPVD1 and STBD1 As Novel AMPK Substrates
    Chemical genetic screen identifies Gapex-5/GAPVD1 and STBD1 as novel AMPK substrates Ducommun, Serge; Deak, Maria; Zeigerer, Anja; Göransson, Olga; Seitz, Susanne; Collodet, Caterina; Madsen, Agnete Bjerregaard; Jensen, Thomas Elbenhardt; Viollet, Benoit; Foretz, Marc; Gut, Philipp; Sumpton, David; Sakamoto, Kei Published in: Cellular Signalling DOI: 10.1016/j.cellsig.2019.02.001 Publication date: 2019 Document version Publisher's PDF, also known as Version of record Document license: CC BY-NC-ND Citation for published version (APA): Ducommun, S., Deak, M., Zeigerer, A., Göransson, O., Seitz, S., Collodet, C., Madsen, A. B., Jensen, T. E., Viollet, B., Foretz, M., Gut, P., Sumpton, D., & Sakamoto, K. (2019). Chemical genetic screen identifies Gapex- 5/GAPVD1 and STBD1 as novel AMPK substrates. Cellular Signalling, 57, 45-57. https://doi.org/10.1016/j.cellsig.2019.02.001 Download date: 24. Sep. 2021 Cellular Signalling 57 (2019) 45–57 Contents lists available at ScienceDirect Cellular Signalling journal homepage: www.elsevier.com/locate/cellsig Chemical genetic screen identifies Gapex-5/GAPVD1 and STBD1 as novel AMPK substrates T Serge Ducommuna,b,1, Maria Deaka, Anja Zeigererc,d,e, Olga Göranssonf, Susanne Seitzc,d,e, Caterina Collodeta,b, Agnete B. Madseng, Thomas E. Jenseng, Benoit Violleth,i,j, Marc Foretzh,i,j, ⁎ Philipp Guta, David Sumptonk, Kei Sakamotoa,b, a Nestlé Research, École Polytechnique Fédérale de Lausanne (EPFL) Innovation Park, bâtiment G, 1015 Lausanne, Switzerland b School of Life Sciences, EPFL, 1015 Lausanne, Switzerland
    [Show full text]